BRPI0403979A - composições contendo oligossacarìdeos - Google Patents

composições contendo oligossacarìdeos

Info

Publication number
BRPI0403979A
BRPI0403979A BRPI0403979-3A BRPI0403979A BRPI0403979A BR PI0403979 A BRPI0403979 A BR PI0403979A BR PI0403979 A BRPI0403979 A BR PI0403979A BR PI0403979 A BRPI0403979 A BR PI0403979A
Authority
BR
Brazil
Prior art keywords
compositions containing
containing oligosaccharides
oligosaccharides
saccharide
pathogens
Prior art date
Application number
BRPI0403979-3A
Other languages
English (en)
Inventor
Jonathan Robert Rhoades
Robert Rastall
Glenn R Gibson
Original Assignee
Novartis Nutrition Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Nutrition Ag filed Critical Novartis Nutrition Ag
Publication of BRPI0403979A publication Critical patent/BRPI0403979A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"COMPOSIçõES CONTENDO OLIGOSSACARìDEOS". A presente invenção refere-se às composições contendo um sacarídeo para a inibição da adesão de agentes patogênicos às células de mamíferos.
BRPI0403979-3A 2003-09-19 2004-09-20 composições contendo oligossacarìdeos BRPI0403979A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0321996.1A GB0321996D0 (en) 2003-09-19 2003-09-19 Organic compounds

Publications (1)

Publication Number Publication Date
BRPI0403979A true BRPI0403979A (pt) 2006-02-21

Family

ID=29266309

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0403979-3A BRPI0403979A (pt) 2003-09-19 2004-09-20 composições contendo oligossacarìdeos

Country Status (5)

Country Link
US (2) US7842678B2 (pt)
BR (1) BRPI0403979A (pt)
GB (1) GB0321996D0 (pt)
TW (2) TWI337079B (pt)
WO (1) WO2005027663A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005044861A1 (en) * 2003-10-31 2005-05-19 Wyeth Holdings Corporation Polysaccharides of helicobacter pylori
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
US20060246146A1 (en) * 2005-04-29 2006-11-02 Mcmahon Robert J Method of increasing the salivary sialic acid content in a mammal
US20070166242A1 (en) * 2005-12-19 2007-07-19 Kross Robert D Oral care product and method for the reduction of dental caries through inclusion of mannan and galactomannan polysaccharides in dentifrice formulations
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
EP2296805B1 (en) * 2008-04-21 2017-11-08 Commonwealth Scientific and Industrial Research Organisation Method and apparatus for forming titanium-aluminium based alloys
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
JP2012518635A (ja) 2009-02-24 2012-08-16 リター ファーマシューティカルズ インコーポレイテッド プレバイオティック製剤および使用方法
IT1395068B1 (it) * 2009-08-07 2012-09-05 Inalco Spa Processo per la produzione di galatto-oligosaccaridi ultrapuri
WO2011093907A1 (en) * 2010-02-01 2011-08-04 Corn Products International, Inc. High-purity galactooligosaccharides and uses thereof
WO2011098240A2 (en) * 2010-02-15 2011-08-18 Cargill, Incorporated Epimerisation of saccharides
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc PREBIOTIC FORMULATIONS AND METHODS OF USE
US9314494B2 (en) 2012-05-25 2016-04-19 The United States Of America, As Represented By The Secretary Of Agriculture Cranberry xyloglucan oligosaccharide composition
DE102013022109A1 (de) * 2013-12-27 2015-07-02 Markus Paulmichl Oligo-(2-7)-Glucuronat umfassendes Medikament (zweite medizinische Indikation)
CN107668208A (zh) * 2017-11-13 2018-02-09 海普诺凯营养品有限公司 一种促进肠道健康的配方奶粉
EP3542641B1 (de) 2018-03-20 2023-07-12 Universität Hohenheim Lactulosehaltiges produkt sowie verfahren zur herstellung eines lactulosehaltigen produkts

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895838A (en) * 1988-03-09 1990-01-23 Trustees Of Boston University Method for provoking angiogenesis by administration of angiogenically active oligosaccharides
US5260280A (en) * 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
JPH0779684B2 (ja) * 1989-02-27 1995-08-30 森永乳業株式会社 ビフィズス菌増殖促進組成物
US5459257A (en) * 1993-01-11 1995-10-17 Dainippon Ink And Chemicals, Inc. Sulfated oligoglycoside acylate and antiviral agent containing the same as active ingredient
DE4330773A1 (de) 1993-09-10 1995-03-16 Laevosan Gmbh & Co Kg Blockierung der Anlagerung von Keimen an menschliche Zellen
US20020173483A1 (en) * 1999-02-19 2002-11-21 Cho-Chou Kuo Chlamydia oligosaccharides
WO1998016111A1 (en) * 1996-10-16 1998-04-23 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
EP0973498B1 (en) 1997-03-25 2005-01-12 Takeda Chemical Industries, Ltd. Gastrointestinal mucosa-adherent pharmaceutical composition
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
DE69837551T2 (de) * 1997-05-15 2007-12-20 University Of Washington, Seattle Zusammensetzung und verfahren zur behandlung der alzheimer'schen krankheit und anderen amyloidosen
EP0994656B1 (fr) * 1997-07-05 2006-04-19 Societe Des Produits Nestle S.A. dessert congelé avec bactéries lactiques et fibres fermentescibles
US6013635A (en) * 1998-05-28 2000-01-11 Synsorb Biotech, Inc. Treatment of C. difficile toxin B associated conditions
ATE260639T1 (de) * 1998-07-27 2004-03-15 E L Management Corp Sialylzucker und ihre derivaten enthaltende topische zubereitungen
IT1304170B1 (it) * 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
IT1304183B1 (it) * 1998-12-18 2001-03-08 Indena Spa Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
EP1062876A1 (en) * 1999-02-25 2000-12-27 Societe Des Produits Nestle S.A. Caseinoglycomacropeptides as calcification agent
JP4273277B2 (ja) * 1999-06-30 2009-06-03 大塚製薬株式会社 オリゴ糖補給組成物
BR0013780A (pt) * 1999-09-07 2002-05-14 Nestle Sa Processo de melhoramento da pele e da pelagem de animais de estimação
GB9927603D0 (en) * 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
AU2001233529A1 (en) * 2000-02-10 2001-08-20 Andrew W. Bruce Probiotic therapy for newborns
US6260280B1 (en) * 2000-02-11 2001-07-17 Keith Rapisardi Knife with ceramic blade
EP1261259B2 (en) * 2000-03-10 2012-06-06 Mars Uk Limited Treatment of infection in animals
CA2415918C (en) * 2000-07-14 2010-06-01 Societe Des Produits Nestle S.A. Agent for inhibiting adhesion of the pathogenic flora of the skin
JP4873824B2 (ja) * 2000-08-01 2012-02-08 オリザ油化株式会社 糖質吸収阻害剤およびその製造方法
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
US8227448B2 (en) 2000-12-27 2012-07-24 N.V. Nutricia Nutritional composition with health promoting action containing oligosaccharides
IS6085A (is) * 2001-09-26 2003-03-27 Genis Ehf. Lyfjablanda með kítósan óligómerum
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti
EP2272522B1 (en) * 2002-06-28 2017-09-06 Nestec S.A. Therapeutic compositions for use in prophylaxis or treatment of diarrheas

Also Published As

Publication number Publication date
TWI337079B (en) 2011-02-11
US7842678B2 (en) 2010-11-30
TWI398254B (zh) 2013-06-11
TW200526234A (en) 2005-08-16
GB0321996D0 (en) 2003-10-22
US20110021417A1 (en) 2011-01-27
WO2005027663A2 (en) 2005-03-31
US20060287276A1 (en) 2006-12-21
TW201100084A (en) 2011-01-01
WO2005027663A3 (en) 2005-07-07

Similar Documents

Publication Publication Date Title
BRPI0403979A (pt) composições contendo oligossacarìdeos
BRPI0519414A2 (pt) composiÇço oral, composiÇço em pasta ou gel, e, mÉtodos para inibir crescimento bacteriano na cavidade oral, e para manter saéde sistÊmica
BRPI0411528A (pt) uso de isomalte como prebiótico
TN2010000136A1 (en) Composition comprising sphingosine 1 phosphate (s1p) receptor modulators
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
BRPI0818672B8 (pt) composições, composições farmacêuticas e usos de 2'flúor-2'-desoxitetra-hidrouridinas
BRPI0606318B8 (pt) composto, composição, e, uso de um composto
MY140740A (en) Resin compositions
BR0312975A (pt) Forma cristalina de agonista de receptor adrenérgico ß2
TW200609235A (en) Tetraazabenzo[e]azulene derivatives and analogs thereof
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
BRPI0609322A (pt) composições abosorvìveis de alfa-cianoacrilato
BRPI0411361A (pt) composições oftálmicas contendo uma combinação sinérgica de dois polìmeros
MA30042B1 (fr) Composes calcilytiques
BRPI0920355B8 (pt) composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina
DE602006017724D1 (de) Salicylsäurederivate
BR0116319A (pt) Composição herbicida
BRPI0417157A (pt) composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
BR0311327A (pt) Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo
MX2009008324A (es) Compuestos 6´-sustituidos que tienen afinidad con el receptor de 5-hidroxitriptamina-6.
BR0308184A (pt) Composição oftálmica compreendendo ascomicina
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
BR0208813A (pt) Composições contendo imidazotriazinona para a aplicação nasal
ATE512593T1 (de) Hydroxyapatithaltiger kaugummi

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: NESTEC S.A. (CH)

Free format text: TRANSFERIDO DE: NOVARTIS AG .

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2324 DE 21-07-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 45/06 (2006.01), A23L 33/21 (2016.01), A61K 3